Selumetinib price in China in 2023

Selumetinib is an inhibitor of mitogen-activated protein kinase kinase 1 and 2 (MEK1/2). MEK1/2 protein is an upstream regulator of the extracellular signal-related kinase (ERK) pathway. Both MEK and ERK are important components of the RAS-regulated RAF-MEK-ERK pathway, which is commonly activated in different types of cancer.

Selumetinib received Breakthrough Therapy Designation from the U.S. FDA in April 2019, Rare Pediatric Disease Designation in December 2019, Orphan Drug Designation in February 2018, and EU Orphan Designation in August 2018 for the treatment of plexiform neurofibromas (PN) in pediatric patients with neurofibromatosis type 1 (NF1). Doctors will check how well your heart, eyes, and liver are working before and during treatment with selumetinib. Treatment should be continued as long as the patient's condition improves or remains stable and side effects are tolerated. If certain side effects occur, your doctor may reduce your dose or stop treatment temporarily or permanently.

SelumetinibThe original drug has been launched in China, but it has not yet entered the scope of medical insurance. SpecificationThe price of 10mg*60 tablets per box may be more than 20,000 yuan, which is relatively expensive. SelumetinibOriginal drug marketed overseas, the price of 10mg*60 pills per box may be more than 50,000 yuan, and the price of 25mg*60 pills per box may be 1 More than RMB 00,000 (the price may fluctuate due to the exchange rate). The ingredients of the original version of selumetinib sold at home and abroad are basically the same. There is currently no generic version of selumetinib on the market. For more drug information and specific prices, please consult Yaode Medical Consultants.